GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use

Tekijä Vis, Roeland, Lavalaye, Jules, van de Garde, Ewoudt MW
Julkaisussa EJNMMI Res (2015)

Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy

Tekijä Bui, Tam Binh V, Burgers, Desirée MT, Agterof, Mariette J, van de Garde, Ewoudt MW
Julkaisussa Breast Cancer (Auckl) (2019)

Validation of an automated method for compounding monoclonal antibody patient doses: Case studies of Avastin(®) (bevacizumab), Remicade(®) (infliximab) and Herceptin(®) (trastuzuma...

Tekijä Peters, Bas J.M., Capelle, Martinus A.H., Arvinte, Tudor, van de Garde, Ewoudt M.W.
Julkaistu 2013

Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis

Tekijä Spoorenberg, Simone MC, Bos, Willem Jan W, Heijligenberg, Rik, Voorn, Paul GP, Grutters, Jan C, Rijkers, Ger T, van de Garde, Ewoudt MW
Julkaistu 2014

Altered splenic [(89)Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism?

Tekijä Adams, Human, Meek, Bob, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, Keijsers, Ruth G, Grutters, Jan C
Julkaisussa Am J Nucl Med Mol Imaging (2020)

[(89)Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study

Tekijä Adams, Human, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, van Dongen, Guus AMS, Grutters, Jan C, Keijsers, Ruth G
Julkaisussa Am J Nucl Med Mol Imaging (2019)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study

Tekijä van de Garde, Ewoudt MW, Endeman, Henrik, van Hemert, Remco N, Voorn, G Paul, Deneer, Vera HM, Leufkens, Hubert GM, van den Bosch, Jules MM, Biesma, Douwe H
Julkaistu 2007

Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer

Tekijä Cramer-van der Welle, Christine M., Peters, Bas J.M., Schramel, Franz M.N.H., Klungel, Olaf H., Groen, Harry J.M., van de Garde, Ewoudt M.W.
Julkaisussa Eur Respir J (2018)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative

Tekijä Reesink, Daan J., van de Garde, Ewoudt M.W., Somford, Diederik M., Meijer, Richard P., Los, Maartje, Biesma, Douwe H., Horenblas, Simon, van Melick, Harm H.E., van der Nat, Paul B.
Julkaisussa Eur Urol Open Sci (2021)

Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline

Tekijä Sieswerda, Elske, de Boer, Mark G.J., Bonten, Marc M.J., Boersma, Wim G., Jonkers, René E., Aleva, Roel M., Kullberg, Bart-Jan, Schouten, Jeroen A., van de Garde, Ewoudt M.W., Verheij, Theo J., van der Eerden, Menno M., Prins, Jan M., Wiersinga, W. Joost
Julkaisussa Clin Microbiol Infect (2021)